Diabetes Device Market Scrutiny by Types and Applications to Grow at 7.3% of CAGR till 2026 | Medtronic, Insulet, Dexcom, Sanofi, Tandem, etc.

Based on current analysis, the global diabetes devices market was valued at USD21.93 billion in 2018 and is expected to reach USD 38.53 billion by 2026, at a CAGR 7.3% Rising awareness about therapeutics for diabetes and diabetes management among patients is strengthening growth of the market.

Companies profiled for this market study
Medtronic, Insulet, Dexcom, Sanofi, Tandem, Ypsomed, Eli Lilly, Bayer Healthcare AG, Becton Dickinson and Company, Novo Nordisk A/S, Abbott Laboratories, F. Hoffman-La Roche AG and Johnson & Johnson.

To Request for a PDF Sample, Click Here @ https://www.reportsanddata.com/sample-enquiry-form/1488

Continuous technological developments and advancements in the product is another factor expected to create potential opportunities in the market and continue over the forecast period. The diabetes devices offer a solution to diabetes affected patients manage the sugar level in the blood. diabetes device are devices used for checking the sugar level in the blood, it is also used to control glycemic improvement and reduction in hypoglycemia. The cost-effectiveness of devices such as lancets, self-monitoring blood glucose meters, testing strips, and continuous monitoring devices is completely influencing revenue of the market. Major international market players are involving themselves in various collaborations, partnerships and acquisitions to give further rise to the diabetes device market in the forthcoming years.

Moreover, multiplying prevalence of diabetes, rising awareness regarding diabetes care, growing intensity of obesity and technological progressions are further fueling the market growth of diabetes devices. According to WHO, over 1.9 billion people were identified to be overweight, of which, around 600 million people were obese. Obese population are likely to be detected with type 1, type 2 or gestational diabetes. This information helps us to understand that diabetes market is growing at an increasing rate due to market drivers mentioned above.

Key findings from the report

o Asia-Pacific is anticipated to grow enormously at CAGR of 8.2% during the forecast period, owing to factors, such as a high prevalence of diabetes, growing obese population, and government initiatives of raising awareness regarding diabetic care

o Medtronic PLC received the US Food and Drug Administration (FDA) approval for Guardian (TM) Connect continuous glucose monitoring (CGM) system, for people with diabetes aged between 14-75 years. such market initiatives are proving to be profitable for the growth of diabetes device market

o Glucose monitoring devices dominated the diabetes devices market by registering 52% of market share in diabetes device products

o Expansion of the global diabetes management devices market is also supported by prominent investments, scope of infiltration in middle- and low-income regions and increasing awareness in patient population about effective diabetes control and thus preclusion of disease related complications

o Opportunities for global diabetes device market are adding up due to development of artificial pancreas and development of home infusion therapy. Major market players are developing products that designed to instrument glucose monitoring technologies

o North America is leading the regional market, followed by Europe owing to higher number of obese individuals, advanced healthcare infrastructure, availability of technologically advanced products and overall health consciousness.

o The National Healthcare System will expect children with 12 years of age on an insulin pump to gain sufficient diabetes control as a result of being on an insulin pump

o Eli Lilly and Sanofi have strategic research projects to develop Glucose Responsive Insulins (GRIs). GRIs are insulins which automatically activate or deactivate in response to changing glucose levels in the blood. They improve diabetes treatment efficacy and reduce the incidence of hyperglycemia and hypoglycemia.

Do you have questions about the Report or want to inquire about a Discount? Ask our Expert @ https://www.reportsanddata.com/discount-enquiry-form/1488

Type (Revenue in USD Million; 2016-2026)
o Glucose Monitoring Devices
o Self- monitoring blood glucose meters
o Blood glucose testing strips
o Lancets
o Continuous glucose monitoring meters
o Insulin Delivery Devices
o Insulin syringes
o Insulin pens
o Insulin pumps
o Diabetes Management Software
o Artificial Pancreas System

Distribution Channels (Revenue in USD Million; 2016-2026)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
o Diabetes Clinics/ Centers
o Others

Regional Outlook (Revenue in USD Million; 2016-2026)
o North America (United States, Canada and Mexico)
o Europe (Germany, France, UK, Russia and Italy)
o Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
o South America (Brazil, Argentina, Colombia)

Read the Comprehensive Report with a meticulous TOC and panoramic coverage of the market @ https://www.reportsanddata.com/report-detail/diabetes-device-market

In conclusion, the Diabetes Device Market report is a reliable source for accessing the Market data that will exponentially accelerate your business. The report provides the principal locale, economic scenarios with the item value, benefit, supply, limit, generation, request, Market development rate, and figure and so on. Besides, the report presents a new task SWOT analysis, speculation attainability investigation, and venture return investigation.

Contact Us:

John Watson
Head of Business Development
Address: 40 Wall St. 28th floor New York City, NY 10005 United States
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com

About Us:

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.